Affiliation “Department of Clinical Science (K2), University of Bergen, Bergen, Norway” was omitted from the paper. This affiliation has now been added for author Thomas Andersen.
The original version of this article has been updated.
Summary
Keywords
extracellular matrix, chest pain, acute coronary syndrome, risk factors, biomarkers, Podocan
Citation
Andersen T, Ueland T, Aukrust P, Nilsen DW, Grundt H, Staines H and Kontny F (2025) Correction: Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes. Front. Cardiovasc. Med. 12:1650098. doi: 10.3389/fcvm.2025.1650098
Received
19 June 2025
Accepted
26 June 2025
Published
07 July 2025
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2025
Updates
Copyright
© 2025 Andersen, Ueland, Aukrust, Nilsen, Grundt, Staines and Kontny.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Thomas Andersen thomas.andersen@sus.no
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.